Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome

Fertil Steril. 2008 Dec;90(6):2318-23. doi: 10.1016/j.fertnstert.2007.10.030. Epub 2008 Jan 14.

Abstract

Objective: To evaluate the role of the androgen receptor (AR) gene CAG repeat in women with polycystic ovary syndrome (PCOS).

Design: Case control study.

Setting: University department of obstetrics and gynecology.

Patient(s): Women with (n = 114) or without (n = 205) PCOS.

Intervention(s): Peripheral blood sampling was done for DNA analysis and serum hormone measurements.

Main outcome measure(s): CAG repeat length and serum androgen levels.

Result(s): No statistically significant CAG repeat length differences were found between patients and controls. We conducted a detailed analysis after dividing PCOS patients according to their free testosterone levels. The high free testosterone group had a statistically significantly longer mean biallelic average (24.0 +/- 2.0 vs. 23.0 +/- 1.5), short (22.5 +/- 1.8 vs. 21.7 +/- 1.9), and long (25.5 +/- 2.9 vs. 24.4 +/- 1.9) allelic lengths than the normal free testosterone group. In PCOS patients, a statistically significant correlation was found between biallelic average length and free testosterone concentration, either unadjusted or after adjustment.

Conclusion(s): The AR gene CAG repeat polymorphism may contribute to the serum concentration of free testosterone in PCOS patients. A subset of PCOS patients with relatively longer CAG repeats (less AR activity) tended to show a higher serum androgen concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Genotype
  • Humans
  • Phenotype
  • Polycystic Ovary Syndrome / genetics*
  • Polycystic Ovary Syndrome / metabolism
  • Polymorphism, Genetic*
  • Receptors, Androgen / genetics*
  • Receptors, Androgen / metabolism
  • Testosterone / blood
  • Trinucleotide Repeats*
  • Young Adult

Substances

  • AR protein, human
  • Receptors, Androgen
  • Testosterone